- $1.36bn
- $1.05bn
- $1.29bn
Annual cashflow statement for Progyny, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 65.8 | 30.4 | 62 | 54.3 | 58.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 43.5 | 115 | 138 | 144 | 152 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -51.3 | -59.5 | -17.4 | -11.8 | 2.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 26 | 80.4 | 189 | 179 | 210 |
| Capital Expenditures | -2.13 | -3.24 | -3.64 | -5.41 | -18.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10.9 | -40.6 | -197 | 201 | -141 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 8.77 | -43.9 | -201 | 196 | -159 |
| Financing Cash Flow Items | -16.6 | -10.9 | -15.9 | -10.7 | -17.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -13.7 | -7.86 | -11.1 | -310 | -99.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.1 | 28.7 | -22.8 | 65 | -48.1 |